Aligen Revenue and Competitors
Estimated Revenue & Valuation
- Aligen's estimated annual revenue is currently $2.2M per year.
- Aligen's estimated revenue per employee is $201,000
Employee Data
- Aligen has 11 Employees.
- Aligen grew their employee count by 10% last year.
Aligen's People
| Name | Title | Email/Phone |
|---|
Aligen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.9M | 79 | 30% | N/A | N/A |
#2 | $91.5M | 455 | 7% | N/A | N/A |
#3 | $26.1M | 130 | 25% | $35M | N/A |
#4 | $15.3M | 76 | -4% | N/A | N/A |
#5 | $6.6M | 33 | -25% | N/A | N/A |
#6 | $5.6M | 28 | -7% | N/A | N/A |
#7 | $4.2M | 21 | -36% | N/A | N/A |
#8 | $10.1M | 50 | -25% | N/A | N/A |
#9 | $225.5M | 1122 | 19% | N/A | N/A |
#10 | $3.2M | 16 | -27% | N/A | N/A |
What Is Aligen?
Aligen Therapeutics is pharmaceutically focused on the development of cannabinoid therapeutic medications- Procanol®, Epilene® and Serenex®. Irvine Therapeutics is currently expanding its clinical trials with the efforts of receiving FDA approval for treatment.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$2.2M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aligen News
2022-04-06 - 20-0 sezona kompletirana - T1 je ponovo prvak LCK lige ...
U tre?oj partiji T1 dolazi do velike prednosti na po?etku, ali Gen.G uspeva da se dri za slamku spasa u vidu zmajeva i do?e do dragocenog...
2022-03-22 - Ankaran ali Gen-I Volley?
Ankaran ali Gen-I Volley? Ale Sorta · port 23. 03. 2022, 06.00. Odbojkarska sreda bo postregla tudi s tremi dvoboji ?etrtfinala v moki konkurenci.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | 0% | N/A |
#2 | $0.8M | 11 | 0% | $21.5M |
#3 | $1.7M | 11 | -45% | N/A |
#4 | $1M | 11 | 0% | N/A |
#5 | $1M | 11 | -8% | N/A |